RxDoctor Payments Data

Gary Garrett, MD

Family Medicine · Mesquite, TXNPI 1932158581

Payments from drug & device makers

$2,373in general payments, 2019–2025

Across 148 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$372
  • Novo Nordisk$255
  • Pfizer$255
  • Merck$216
  • Amarin Pharma, Inc.$207
  • GSK$131
  • plus $936 from 17 others

What the payments were for

  • Food & beverage$2,361100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,373 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$46,968
Medicare patients
121
Services billed
635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$62,537
JanuviaSitagliptin Phosphate31$36,625
MounjaroTirzepatide28$31,996
FarxigaDapagliflozin Propanediol16$24,701
EliquisApixaban20$15,991
Lantus SolostarInsulin Glargine,hum.Rec.Anlog42$5,593
Atorvastatin Calcium356$3,079
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen86$1,707
Fluticasone Propionate69$1,561
Rosuvastatin Calcium158$1,502
Lisinopril224$1,422
Albuterol Sulfate HfaAlbuterol Sulfate28$1,307
Bupropion XlBupropion Hcl52$1,301
Levothyroxine Sodium129$1,256
Amlodipine Besylate229$1,227

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$255$62,53754 claims
MerckJanuvia$216$36,62531 claims
Lilly USA, LLCMounjaro$121$31,99628 claims
AstraZenecaFarxiga$372$24,70116 claims
PfizerEliquis$255$15,99120 claims
AbbVieSynthroid$20$59011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Mesquite

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →